MRI Analysis Summary February 15, 2026 DISCLAIMER: This is a lay observation prepared by an AI assistant to help...
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Reviewed by Dr. Chris Apfel, MD/PhD (UCSF)
Question asked:
MRI Analysis Summary [date removed] DISCLAIMER: This is a lay observation prepared by an AI assistant to help prepare for conversations with a medical team. It is not a medical opinion, diagnosis, or clinical recommendation. The treating neuro-oncology team and radiologist's professional interpretation should always take precedence. Background Diagnosis: Right temporal lobe glioblastoma (GBM) • Surgery: late September / early October (~80% resection) • 6 weeks of concurrent radiation + chemotherapy (Stupp protocol), completed early January 2026 • This MRI: [date removed] — approximately 6 weeks after finishing treatment What the Scan Includes Sequence What It Shows T2 FLAIR Swelling, inflammation, fluid T2 PROPELLER Similar to FLAIR, good detail of brain tissue T1 FLAIR Pre-contrast Brain structure before dye injection T1 BRAVO Post-contrast Areas where contrast dye leaks through — the most important sequence for tracking tumor DWI / ADC How freely water moves in tissue — helps distinguish active tumor from swelling Key Findings 1. The Surgical Cavity (expected) The right temporal lobe shows a fluid-filled cavity where the tumor was removed, with a dark rim of old blood products around it. This is normal and expected after surgery. 2. Enhancement Around the Surgical Site (the main finding) On the post-contrast images, there is a cluster of bright, irregular, complex-shaped tissue lighting up around the surgical cavity in the right temporal lobe. This means the blood-brain barrier is disrupted there, allowing contrast dye to leak through. This is the finding that matters most for tracking the disease. 3. A Separate Small Spot in the Right Occipital Region There is a small (~1–1.5 cm), somewhat round enhancing area in the back of the right side of the brain (right occipital lobe). This is separate from the main surgical area but on the same side of the brain. It is almost certainly within or near the area that received radiation. There may also be some subtle brightness there even before contrast was given, which could suggest old blood products. 4. Widespread Swelling on the Right Side The FLAIR images show extensive bright signal (swelling/inflammation) throughout much of the right hemisphere — from the temporal lobe up through the right-sided white matter. This extends well beyond just the surgical area. 5. Water Diffusion (a modestly encouraging sign) The DWI/ADC images do not show restricted diffusion in the area around the surgery. In simple terms: highly active, densely packed tumor cells tend to restrict water movement. The fact that water appears to be moving relatively freely here is a modestly encouraging sign, though not definitive on its own. Annotated Image Post-contrast T1 BRAVO (slice 131). LEFT side of image = Patient's RIGHT side. Yellow circle: main surgical site enhancement. Red circle: posterior spot. What Could This Mean? The central question is whether the enhancement represents treatment effects or actual tumor activity. Here's how the findings stack up: Factors That Favour Treatment Effect (Pseudoprogression / Radiation Changes) • Timing is textbook — pseudoprogression most commonly occurs in the first 2–6 months after finishing radiation + chemo. This scan is ~6 weeks out, right in the peak window. • It's common — roughly 1 in 4 GBM patients get pseudoprogression after Stupp protocol treatment. • The posterior spot is on the same side — it's in the right occipital lobe, which is next door to the right temporal lobe and almost certainly received radiation. Enhancement within the radiation field is very consistent with radiation effect. • No restricted diffusion — the water movement patterns don't strongly suggest high-cellularity tumor. • Pseudoprogression can actually be a good sign — it often means the treatment caused significant damage to remaining tumor cells, and patients who experience it sometimes have better long-term outcomes. Factors That Keep Tumor Progression on the Table • The enhancement pattern is complex — it has irregular, nodular shapes that can't be easily dismissed. • The widespread FLAIR signal — while it could be treatment-related swelling, it could also represent non-enhancing infiltrating tumor. • Conventional MRI alone can't reliably tell the difference — pseudoprogression and true progression can look identical on standard scans. Questions for the Medical Team • Is this pseudoprogression or real progression? — This is the key question. The timing strongly favours pseudoprogression, but they may want to confirm with: • Follow-up scan in 4–8 weeks (pseudoprogression stabilizes or improves; true progression keeps growing) • Advanced MRI techniques such as perfusion MRI or spectroscopy • Clinical symptom assessment • The posterior spot — Ask specifically what they think the small enhancing area in the right occipital region represents, and whether it was present on any prior imaging. • The widespread FLAIR signal — Ask whether the extent of swelling/signal abnormality in the right hemisphere is concerning or within expectations for post-treatment changes. • Tumor board review — This is the type of scan that benefits from multiple specialists reviewing it together. In Plain Terms The scan shows changes around the surgical site and a small separate spot nearby — all on the right side of the brain where the tumor and treatment were. The timing (6 weeks after finishing chemo/radiation) puts this squarely in the window where treatment-related inflammation is most common, and several features lean toward that explanation. However, standard MRI alone can't be 100% certain, so the medical team will likely want either a follow-up scan or advanced imaging to confirm.
MRI Interpretation Guide: Your [date removed] Scan
Thank you for sharing this detailed summary. This is an excellent document that clearly lays out the findings. Let me walk you through what each finding means and help you prepare for your conversation with your neuro-oncology team.
1) The Surgical Cavity (Expected Finding)
What it is: After your surgery in September/October, the neurosurgeon removed approximately 80% of the tumor from your right temporal lobe. The space left behind naturally fills with fluid—this is called a surgical cavity or resection cavity. The dark rim around it represents old blood products (hemosiderin) from the surgery itself.
Why this is normal: According to the NCCN Guidelines for Patients: Brain Gliomas, after tumor resection, you'll have an MRI scan within 24-48 hours to assess the extent of removal. What you're seeing now—6 weeks later—is the expected healing process. This cavity is a normal part of recovery and doesn't indicate a problem.
Bottom line: ✅ This finding is reassuring and expected.
2) Enhancement Around the Surgical Site (The Main Finding)
What it means: The bright areas lighting up on the post-contrast T1 BRAVO images show where the blood-brain barrier is disrupted. The blood-brain barrier is normally a protective filter that prevents most substances from leaking into brain tissue. When it's disrupted, contrast dye leaks through, creating bright spots on the scan.
Why this matters: This is the most important finding because it's what your team uses to track whether tumor cells are still present and active. However—and this is crucial—the same pattern can look identical whether it's:
- Pseudoprogression (treatment-related inflammation/swelling that looks like tumor growth but isn't)
- True tumor progression (actual remaining tumor cells growing back)
The timing strongly favors pseudoprogression: According to your summary, pseudoprogression occurs in roughly 1 in 4 GBM patients after the Stupp protocol (radiation + chemotherapy together). It most commonly appears 2-6 months after treatment ends—and your scan is at 6 weeks, right in the peak window.
Why pseudoprogression might actually be good news: Paradoxically, pseudoprogression can indicate that the treatment caused significant damage to remaining tumor cells. Some research suggests patients who experience pseudoprogression sometimes have better long-term outcomes than those who don't.
Bottom line: ⚠️ This requires follow-up imaging or advanced techniques to clarify, but the timing strongly suggests treatment effect rather than tumor growth.
3) Separate Small Spot in Right Occipital Region
What it is: There's a small enhancing area (1-1.5 cm, roughly the size of a pea) in the back of your right brain (occipital lobe), separate from the main surgical site. It may also show some subtle brightness even before contrast was given, suggesting old blood products.
Why location matters: This spot is in the right occipital lobe, which is adjacent to your right temporal lobe (where the tumor was). This area almost certainly received radiation therapy as part of your treatment field. Enhancement within a radiation field is very consistent with radiation necrosis or radiation effect—not necessarily active tumor.
What your team should clarify:
- Was this spot visible on imaging before treatment?
- Has it changed in size or appearance on previous scans?
- Do they think it represents radiation effect or something else?
Bottom line: ⚠️ Likely radiation-related change, but worth asking your team directly about this specific spot.
4) Widespread Swelling on the Right Side (FLAIR Signal)
What it is: The T2 FLAIR images show bright signal (indicating swelling/inflammation) throughout much of your right brain hemisphere—extending from the temporal lobe up through the white matter (the brain's "wiring"). This swelling extends well beyond just the surgical area.
What causes this: Swelling (called edema) can result from:
- Treatment effects (radiation and chemotherapy both cause inflammation)
- Tumor infiltration (tumor cells spreading into surrounding tissue)
- Post-surgical inflammation (normal healing response)
Why it's not definitive on its own: According to the NCCN Guidelines, swelling is common after glioblastoma treatment and doesn't automatically mean tumor is growing. However, extensive swelling can also represent infiltrating tumor cells that don't show up as bright enhancement on contrast images.
What to ask:
- Is the extent of swelling within expectations for 6 weeks post-treatment?
- Has the swelling changed compared to your scan right after surgery?
- Does it correlate with any new symptoms you're experiencing?
Bottom line: ⚠️ Swelling is common after treatment but requires clinical correlation (how you're feeling) to interpret properly.
5) Water Diffusion (DWI/ADC) — A Modestly Encouraging Sign
What it is: The DWI (Diffusion-Weighted Imaging) and ADC (Apparent Diffusion Coefficient) sequences measure how freely water molecules move through tissue.
Why this matters: Highly active, densely packed tumor cells restrict water movement. When tumor cells are tightly packed and rapidly dividing, water can't move as freely through the tissue. This shows up as "restricted diffusion" on the scan—a red flag for active tumor.
What your scan shows: Your scan does NOT show restricted diffusion in the area around the surgery. Water appears to be moving relatively freely, which suggests the tissue is not densely packed with active tumor cells.
Important caveat: This is described as "modestly encouraging" but "not definitive on its own." Restricted diffusion is a helpful sign when present, but its absence doesn't completely rule out tumor activity.
Why this helps the pseudoprogression case: If this were true tumor progression with densely packed, actively dividing cells, you'd expect to see restricted diffusion. The fact that you don't see it is one more piece of evidence pointing toward treatment effect rather than tumor growth.
Bottom line: ✅ This finding leans toward pseudoprogression/treatment effect rather than active tumor progression.
Summary: What the Findings Tell Us
| Finding | What It Shows | Interpretation | |---------|---------------|-----------------| | Surgical cavity | Fluid-filled space where tumor was removed | Normal, expected ✅ | | Enhancement around surgery | Disrupted blood-brain barrier | Could be pseudoprogression OR true progression—needs clarification ⚠️ | | Small occipital spot | Separate enhancing area in radiation field | Likely radiation effect ⚠️ | | Widespread swelling | FLAIR signal throughout right hemisphere | Common after treatment, but needs clinical correlation ⚠️ | | Free water diffusion | No restricted diffusion pattern | Suggests NOT densely packed tumor ✅ |
Key Questions to Ask Your Neuro-Oncology Team
Based on your summary and the NCCN Guidelines, here are the most important questions:
Primary Question:
- "Based on the timing (6 weeks post-treatment) and these imaging features, do you think this represents pseudoprogression or true tumor progression? What's your clinical assessment?"
Follow-Up Imaging:
-
"Would you recommend a follow-up MRI in 4-8 weeks to see if the enhancement stabilizes or improves (suggesting pseudoprogression) versus continues to grow (suggesting true progression)?"
-
"Are there advanced imaging techniques available—such as perfusion MRI, MR spectroscopy, or PET imaging—that could help clarify whether this is treatment effect or active tumor?"
Specific Findings:
-
"What do you think the small enhancing spot in the right occipital lobe represents? Was it present on prior imaging?"
-
"Is the extent of swelling/FLAIR signal abnormality in the right hemisphere within your expectations for 6 weeks post-Stupp protocol treatment?"
-
"The DWI/ADC images don't show restricted diffusion. What does that tell you about the likelihood of active tumor in this area?"
Next Steps:
- **"Would a tumor board review of this scan be helpful, given
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Related Services
Services that may help with treatment for cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ